Cargando…

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial

Elevated morning and nighttime blood pressures (BP) are associated with increased risk of cardiovascular events such as stroke and myocardial infarction. We compared the long-term changes in morning and nighttime BP in patients with uncontrolled hypertension (office systolic BP between 150 and <1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kario, Kazuomi, Mahfoud, Felix, Kandzari, David E., Townsend, Raymond R., Weber, Michael A., Schmieder, Roland E., Tsioufis, Konstantinos, Pocock, Stuart, Brar, Sandeep, Hettrick, Douglas A., Fahy, Martin, Böhm, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747613/ https://www.ncbi.nlm.nih.gov/pubmed/36241705 http://dx.doi.org/10.1038/s41440-022-01042-8

Ejemplares similares

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial
por: Weber, Michael A., et al.
Publicado: (2022)

Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial
por: Weber, Thomas, et al.
Publicado: (2022)

A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptions
por: Böhm, Michael, et al.
Publicado: (2021)

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy
por: Kario, Kazuomi, et al.
Publicado: (2019)

Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2017)

Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials
por: Kirtane, Ajay J., et al.
Publicado: (2023)

Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study
por: Saxena, Manish, et al.
Publicado: (2021)

Association of lower nighttime diastolic blood pressure and hypoxia with silent myocardial injury: The Japan Morning Surge‐Home Blood Pressure study
por: Kubota, Kana, et al.
Publicado: (2020)

Renal denervation after the symplicity HTN-3 trial
por: Warchoł-Celińska, Ewa, et al.
Publicado: (2014)

Renal Denervation after Symplicity HTN-3: An Update
por: Persu, Alexandre, et al.
Publicado: (2014)

Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry
por: Schmieder, Roland E, et al.
Publicado: (2022)

Procedural and anatomical predictors of renal denervation efficacy using two radiofrequency renal denervation catheters in a porcine model
por: Wolf, Milan, et al.
Publicado: (2018)

SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
por: Patel, Hitesh C, et al.
Publicado: (2014)

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial
por: Worthley, Stephen G., et al.
Publicado: (2013)

Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model
por: Sharp, Andrew S.P., et al.
Publicado: (2022)

Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2019)

Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial
por: Azizi, Michel, et al.
Publicado: (2022)

Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study
por: Kario, Kazuomi, et al.
Publicado: (2020)

Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension
por: Fadl Elmula, Fadl Elmula M., et al.
Publicado: (2015)

Clinical Implications of the Change in Glomerular Filtration Rate with Adrenergic Blockers in Patients with Morning Hypertension: The Japan Morning Surge-1 Study
por: Shibasaki, Seiichi, et al.
Publicado: (2013)

Comparison of nighttime measurement schedules using a wrist‐type nocturnal home blood pressure monitoring device
por: Tomitani, Naoko, et al.
Publicado: (2021)

Reproducibility of nighttime home blood pressure measured by a wrist‐type nocturnal home blood pressure monitoring device
por: Tomitani, Naoko, et al.
Publicado: (2021)

Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria
por: Schönherr, Elisabeth, et al.
Publicado: (2016)

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE
por: Mahfoud, Felix, et al.
Publicado: (2023)

Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension
por: Schmieder, Roland, et al.
Publicado: (2023)

Renal Denervation for Chronic Heart Failure: Background and Pathophysiological Rationale
por: Böhm, Michael, et al.
Publicado: (2017)

Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension
por: Schmieder, Roland E., et al.
Publicado: (2021)

Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension
por: Kario, Kazuomi, et al.
Publicado: (2013)

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial
por: Khanal, Suraj, et al.
Publicado: (2014)

Lessons Learned from RADIOSOUND-HTN: Different Technologies and Techniques for Catheter-based Renal Denervation and Their Effect on Blood Pressure
por: Lurz, Philipp, et al.
Publicado: (2019)

New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2019)

Treating resistant hypertension: role of renal denervation
por: Urban, Daniel, et al.
Publicado: (2013)

Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension
por: Rakugi, Hiromi, et al.
Publicado: (2014)

A New Baroreceptor Sensitivity-Restoring Ca-Channel Blocker Diminishes Age-Related Morning Blood Pressure Increase in Hypertensive Patients: Open-Label Monitoring of Azelnidipine Treatment for Hypertension in the Early Morning (At-HOME) Study
por: Kario, Kazuomi, et al.
Publicado: (2010)

The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD
por: Muñoz, Anna, et al.
Publicado: (2018)

Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension
por: Mahfoud, Felix, et al.
Publicado: (2021)

Self‐measured worksite blood pressure and its association with organ damage in working adults: Japan Morning Surge Home Blood Pressure (J‐HOP) worksite study
por: Tomitani, Naoko, et al.
Publicado: (2020)

Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium
por: Kario, Kazuomi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_edu7a203ri6gr7o4dql1go4tdh